Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 72789-153

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 72789-153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789153 Label (72789153)

72789153 Label (72789153)
This is a description of a pharmaceutical product with the NDC code 72789-153-30. The product is manufactured by HOP Pharmaceuticals and contains three different types of atorvastatin calcium USP: 10 MG, 10MG, and 10 MG. It comes in a bottle with 30 tablets and the lot number is E21621. The tablets are to be taken 3 times a day and the batch is valid until July 2022. The description also includes a warning to consult a doctor about side effects.*
FDA Label Image

Figure-01 (Atorvastatin Figure 01)

FDA Label Image

Figure-02 (Atorvastatin Figure 02)

Figure-02 (Atorvastatin Figure 02)
This is a statistical analysis output from a study over a period of four years. The graph depicts the cumulative hazard percentage over time and a hazard ratio of 0.63 with a confidence interval of (0.48-0.83) and a p-value of 0.001, indicating a statistically significant result. No information is available about the primary endpoint or the population under study.*
FDA Label Image

Figure-03 (Atorvastatin Figure 03)

Figure-03 (Atorvastatin Figure 03)
The text presents a table of percentages of subjects experiencing an event, with two dosages of Atorvastatin (10 mg and 80 mg) being compared. The results show that the higher dosage had a significant reduction in the occurrence of major cardiovascular events compared to the lower dosage. The study also reports a hazard ratio of 0.78 with a statistically significant p-value of 0.0002. The duration of the study is not specified.*
FDA Label Image

Structure (Atorvastatin Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.